153 related articles for article (PubMed ID: 20005943)
1. EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines.
Grafodatskaya D; Choufani S; Ferreira JC; Butcher DT; Lou Y; Zhao C; Scherer SW; Weksberg R
Genomics; 2010 Feb; 95(2):73-83. PubMed ID: 20005943
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
3. Wp specific methylation of highly proliferated LCLs.
Park JH; Jeon JP; Shim SM; Nam HY; Kim JW; Han BG; Lee S
Biochem Biophys Res Commun; 2007 Jun; 358(2):513-20. PubMed ID: 17499215
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
6. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
7. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
[TBL] [Abstract][Full Text] [Related]
8. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
Niller HH; Wolf H; Minarovits J
Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
[TBL] [Abstract][Full Text] [Related]
10. Promoter analysis of epigenetically controlled genes in bladder cancer.
Veerla S; Panagopoulos I; Jin Y; Lindgren D; Höglund M
Genes Chromosomes Cancer; 2008 May; 47(5):368-78. PubMed ID: 18196590
[TBL] [Abstract][Full Text] [Related]
11. [A genome-wide screen for promoter-specific sites of differential DNA methylation during human cell malignant transformation in vitro].
Zeng JL; Zhang B; Yang P; Xiao YM; Wei Q; Wang Q; Li DC; Xing XM; Chen LP; Chen W
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):404-9. PubMed ID: 21756782
[TBL] [Abstract][Full Text] [Related]
12. Retention of unmethylated CpG island alleles in human diploid fibroblast x fibrosarcoma hybrids expressing high levels of DNA methyltransferase.
Kuerbitz SJ; Baylin SB
Cell Growth Differ; 1996 Jun; 7(6):847-53. PubMed ID: 8780898
[TBL] [Abstract][Full Text] [Related]
13. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific and imprinted epigenetic modifications of the human NDN gene.
Lau JC; Hanel ML; Wevrick R
Nucleic Acids Res; 2004; 32(11):3376-82. PubMed ID: 15247330
[TBL] [Abstract][Full Text] [Related]
15. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
17. Global, comparative analysis of tissue-specific promoter CpG methylation.
Schilling E; Rehli M
Genomics; 2007 Sep; 90(3):314-23. PubMed ID: 17582736
[TBL] [Abstract][Full Text] [Related]
18. Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma.
Li Y; Meng G; Guo QN
Exp Mol Pathol; 2008 Jun; 84(3):234-9. PubMed ID: 18501891
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets.
Ordway JM; Bedell JA; Citek RW; Nunberg A; Garrido A; Kendall R; Stevens JR; Cao D; Doerge RW; Korshunova Y; Holemon H; McPherson JD; Lakey N; Leon J; Martienssen RA; Jeddeloh JA
Carcinogenesis; 2006 Dec; 27(12):2409-23. PubMed ID: 16952911
[TBL] [Abstract][Full Text] [Related]
20. Microarray-based DNA methylation profiling: technology and applications.
Schumacher A; Kapranov P; Kaminsky Z; Flanagan J; Assadzadeh A; Yau P; Virtanen C; Winegarden N; Cheng J; Gingeras T; Petronis A
Nucleic Acids Res; 2006; 34(2):528-42. PubMed ID: 16428248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]